ChemicalBook > CAS DataBase List > MI-503

MI-503

Product Name
MI-503
CAS No.
1857417-13-0
Chemical Name
MI-503
Synonyms
mi503;M1-503;mi-503;CS-1946;MI503;MI 503;Inhibitor,MI503,inhibit,MI 503,MI-503,Epigenetic Reader Domain;1-((1H-Pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-;1-((1H-Pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile;1H-Indole-2-carbonitrile, 4-methyl-1-(1H-pyrazol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-
CBNumber
CB22747932
Molecular Formula
C28H27F3N8S
Formula Weight
564.63
MOL File
1857417-13-0.mol
More
Less

MI-503 Property

Boiling point:
782.9±60.0 °C(Predicted)
Density 
1.48±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO : 50 mg/mL (88.55 mM);Water : < 0.1 mg/mL (insoluble)
form 
Solid
pka
14.10±0.50(Predicted)
color 
White to off-white
InChIKey
DETOMBLLEOZTMZ-UHFFFAOYSA-N
SMILES
N1(CC2=CNN=C2)C2=C(C(C)=C(CN3CCC(NC4N=CN=C5SC(CC(F)(F)F)=CC5=4)CC3)C=C2)C=C1C#N
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
456198
Product name
MI-503
Packaging
1mg
Price
$779
Updated
2021/12/16
TRC
Product number
M350055
Product name
MI-503
Packaging
2.5mg
Price
$935
Updated
2021/12/16
Biosynth Carbosynth
Product number
BM170658
Product name
MI 503
Packaging
100
Price
$1100
Updated
2021/12/16
ChemScene
Product number
CS-6217
Product name
MI-503
Purity
99.81%
Packaging
50mg
Price
$1130
Updated
2021/12/16
ChemScene
Product number
CS-6217
Product name
MI-503
Purity
99.81%
Packaging
25mg
Price
$790
Updated
2021/12/16
More
Less

MI-503 Chemical Properties,Usage,Production

Uses

MI-503 is used in the pharmacological inhibition of menin-MLL interaction that blocks progression of MLL leukemia in vivo.

Biochem/physiol Actions

MI-503 is a highly potent menin-MLL interaction inhibitor (cell-free IC50 = 14.7 nM against 1 nM FITC-MLL(4-13) peptide; cellular IC50 = 220 nM using HEK293 MLL-AF9 fusion transfectants) that targets menin MLL-binding site with high affinity (KD = 9.3 nM by ITC). MI-503 selectively inhibits mixed lineage leukemia (MLL) oncogenic fusion-driven cancer progression in cultures (GI50 from 250 to 570 nM; GI50 >5 μM against cells without MLL gene translocation) and is efficacious against human MLL leukemia MV4;  tumor growth in mice in vivo (by 80-100%; 60 mg/kg/day i.p.) with good pharmacokinetic properties, oral bioavailability (73% post 30 mg/kg p.o.), and no adverse effects to the animals.

in vitro

MI-503 occupies the F9 and P13 pockets on menin, forming a hydrogen bond with Tyr276, and also extends beyond the P13 pocket to form hydrogen bonds with Trp341 and Glu366. Treatment of murine bone marrow cells (BMC) transformed with the mLL-AF9 oncogene with MI-503 results in substantial growth inhibition, with GI50 of 0.22 μM. The cell growth inhibitory effect of MI-503 is time-dependent, with a pronounced impact achieved after 7-10 days of treatment.

in vivo

MI-503 achieves a high level in peripheral blood following a single intravenous or oral dose while also showing high oral bioavailability (75%). MI-503 induces strong tumor growth inhibition with once-daily intraperitoneal (i.p.) administration. Treatment with MI-503 results in an over 80% reduction in MV4, 11 tumor volume, and complete tumor regression in two mice. Ten consecutive days of treatment with MI-503 results in a marked delay in the progression of mLL leukemia in mice and significantly reduces leukemia tumor burden. Treatment with MI-503 and MI-463 leads to markedly reduced expression of Hoxa9 and Meis1, downstream targets of mLL fusion proteins substantially upregulated in mLL leukemias.

MI-503 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

MI-503 Suppliers

Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38632
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
More
Less

View Lastest Price from MI-503 manufacturers

Hubei Chuchang Biotech Co., Ltd.
Product
MI-503 1857417-13-0
Price
US $0.00-0.00/mg
Min. Order
1mg
Purity
98%+ HPLC
Supply Ability
50g per month
Release date
2024-03-28

1857417-13-0, MI-503Related Search:


  • mi503
  • mi-503
  • 1-((1H-Pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-
  • MI503;MI 503
  • CS-1946
  • 1H-Indole-2-carbonitrile, 4-methyl-1-(1H-pyrazol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-
  • 1-((1H-Pyrazol-4-yl)methyl)-4-methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile
  • Inhibitor,MI503,inhibit,MI 503,MI-503,Epigenetic Reader Domain
  • M1-503
  • 1857417-13-0
  • 857417-13-0
  • C28H27F3N8S